Justin Finch
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Justin Finch has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
- Jane Margaret Grant-Kels
Dermatology Department University of Connecticut School of Medicine Farmington Connecticut USA
35 shared publications - Liam Zakko
Yale New Haven Hospital
35 shared publications - Marti Jill Rothe
University of Connecticut Health Center
35 shared publications A. Chiaravalloti
Department of Dermatology, University of Connecticut School of Medicine, Farmington, CT
1 shared publicationBreton Yates
Department of Dermatology, University of Connecticut Health Center, 21 South Road, Farmington, Connecticut
1 shared publicationC. LaRosa
Department of Dermatology, University of Connecticut School of Medicine, Farmington, CT
1 shared publication
Latest Publications
- Open Access
- 1 September 2017
- Published by Wolters Kluwer Health in International Journal of Women's Dermatology
- Vol. 3 (3) , 131-139
Laser treatment of medical skin disease in women
Laser treatment is a relatively new and increasingly popular modality for the treatment of many dermatologic conditions. A number of conditions that predominantly occur in women and that have a paucity of effective treatments include rosacea, connective tissue disease, melasma, nevus of Ota, lichen sclerosus (LS), notalgia paresthetica and macular amyloidosis, and syringomas. Laser therapy is an important option for the treatment of patients with these conditions. This article will review the body of literature that exists for the laser treatment of women with these medical conditions.
- 1 September 2017
- Published by Wolters Kluwer Health in International Journal of Women's Dermatology
- Vol. 3 (3) , 131-139
Open AccessLaser treatment of medical skin disease in women
Laser treatment is a relatively new and increasingly popular modality for the treatment of many dermatologic conditions. A number of conditions that predominantly occur in women and that have a paucity of effective treatments include rosacea, connective tissue disease, melasma, nevus of Ota, lichen sclerosus (LS), notalgia paresthetica and macular amyloidosis, and syringomas. Laser therapy is an important option for the treatment of patients with these conditions. This article will review the body of literature that exists for the laser treatment of women with these medical conditions.
- 1 November 2015
- Published by Elsevier in Clinics in Dermatology
- Vol. 33 (6) , 681-686
Laser therapy in dermatology: Kids are not just little people
- 1 November 2015
- Published by Elsevier in Clinics in Dermatology
- Vol. 33 (6) , 681-686
Laser therapy in dermatology: Kids are not just little people
- Open Access
- 1 November 2015
- Published by Taylor & Francis in Drug Design, Development and Therapy
- Vol. ume 9, 6185-6190
Spotlight on tavaborole for the treatment of onychomycosis
Onychomycosis is a fungal nail plate infection that has been increasing in prevalence. A variety of oral and topical anti-fungal agents are currently available but their use is limited by their adverse effect profile, drug–drug interactions, and limited efficacy. Therefore, there is a great need for newer anti-fungal agents. Tavaborole is one of these newer agents and was approved by the US Food and Drug Administration in July 2014 for the topical treatment of mild to moderate toenail onychomycosis. Tavaborole is a novel, boron-based anti-fungal agent with greater nail plate penetration than its predecessors, due to its smaller molecular weight. It has proven through several Phase II and III trials that it can be a safe and effective topical agent for the treatment of mild to moderate toenail onychomycosis without the need for debridement. In this paper, we review the landscape of topical and systemic treatment of onychomycosis, with particular attention to the pharmacokinetics, safety, and efficacy of topical tavaborole.
- 1 November 2015
- Published by Taylor & Francis in Drug Design, Development and Therapy
- Vol. ume 9, 6185-6190
Open AccessSpotlight on tavaborole for the treatment of onychomycosis
Onychomycosis is a fungal nail plate infection that has been increasing in prevalence. A variety of oral and topical anti-fungal agents are currently available but their use is limited by their adverse effect profile, drug–drug interactions, and limited efficacy. Therefore, there is a great need for newer anti-fungal agents. Tavaborole is one of these newer agents and was approved by the US Food and Drug Administration in July 2014 for the topical treatment of mild to moderate toenail onychomycosis. Tavaborole is a novel, boron-based anti-fungal agent with greater nail plate penetration than its predecessors, due to its smaller molecular weight. It has proven through several Phase II and III trials that it can be a safe and effective topical agent for the treatment of mild to moderate toenail onychomycosis without the need for debridement. In this paper, we review the landscape of topical and systemic treatment of onychomycosis, with particular attention to the pharmacokinetics, safety, and efficacy of topical tavaborole.
- 1 March 2015
- Published by Elsevier in Clinics in Dermatology
- Vol. 33 (2) , 197-206
Laser treatment of periocular skin conditions
- 1 March 2015
- Published by Elsevier in Clinics in Dermatology
- Vol. 33 (2) , 197-206
Laser treatment of periocular skin conditions
- 3 January 2013
- Published by Springer Nature
- p. 185-186
Wilson’s Disease (Hepatolenticular Degeneration): Dermatological Features
- 3 January 2013
- Published by Springer Nature
- p. 185-186
Wilson’s Disease (Hepatolenticular Degeneration): Dermatological Features
- 3 January 2013
- Published by Springer Nature
- p. 179-181
Cirrhosis: Dermatological Features
- 3 January 2013
- Published by Springer Nature
- p. 173-175
Primary Biliary Cirrhosis: Dermatological Features
- 3 January 2013
- Published by Springer Nature
- p. 173-175
Primary Biliary Cirrhosis: Dermatological Features
- 3 January 2013
- Published by Springer Nature
- p. 167-169
Hepatitis C Virus: Dermatological Features